Total Payments
$1.4M
2024 Payments
$47,695
Companies
55
Transactions
1,028
Medicare Patients
14,594
Medicare Billing
$2.0M
Payment Breakdown by Category
Other$934,916 (68.7%)
Research$232,964 (17.1%)
Consulting$109,770 (8.1%)
Travel$59,158 (4.3%)
Food & Beverage$23,771 (1.7%)
Education$1,268 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $922,049 | 333 | 67.7% |
| Unspecified | $232,964 | 9 | 17.1% |
| Consulting Fee | $109,770 | 62 | 8.1% |
| Travel and Lodging | $59,158 | 114 | 4.3% |
| Food and Beverage | $23,771 | 487 | 1.7% |
| Honoraria | $12,340 | 4 | 0.9% |
| Education | $1,268 | 16 | 0.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $500.00 | 1 | 0.0% |
| Grant | $27.04 | 2 | 0.0% |
Payments by Type
General
$1.1M
1,019 transactions
Research
$232,964
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $317,908 | 216 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $211,875 | 126 | $0 (2024) |
| AngioDynamics, Inc. | $193,863 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $106,461 | 79 | $0 (2019) |
| Lilly USA, LLC | $97,012 | 75 | $0 (2024) |
| Boston Scientific Corporation | $72,889 | 89 | $0 (2024) |
| Merck Sharp & Dohme LLC | $59,851 | 40 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $51,374 | 37 | $0 (2024) |
| Veryan Medical Incorporated | $41,600 | 2 | $0 (2021) |
| Amgen Inc. | $35,383 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,695 | 59 | Bayer Healthcare Pharmaceuticals Inc. ($13,366) |
| 2023 | $152,834 | 109 | AngioDynamics, Inc. ($34,714) |
| 2022 | $263,167 | 99 | AngioDynamics, Inc. ($141,607) |
| 2021 | $151,689 | 94 | Veryan Medical Incorporated ($41,600) |
| 2020 | $147,144 | 105 | Lilly USA, LLC ($38,400) |
| 2019 | $222,024 | 189 | Janssen Pharmaceuticals, Inc ($105,449) |
| 2018 | $140,891 | 156 | Janssen Pharmaceuticals, Inc ($58,411) |
| 2017 | $236,402 | 217 | Boehringer Ingelheim Pharmaceuticals, Inc. ($74,289) |
All Payment Transactions
1,028 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Heart Failure | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,175.00 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,624.00 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Boston Scientific Corporation | ELUVIA (Device) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: ELUVIA_PI | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $108.57 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,520.00 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Amplitude Vascular Systems, Inc. | — | Food and Beverage | Cash or cash equivalent | $75.35 | General |
| 10/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardio-renal | ||||||
| 10/02/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.62 | General |
| 09/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,608.00 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $980.31 | General |
| Category: Cardio-renal | ||||||
| 09/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $96.52 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Obesity | ||||||
| 09/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $69.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/06/2024 | Boston Scientific Corporation | ELUVIA (Device) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: ELUVIA_PI | ||||||
| 08/29/2024 | Cook Medical LLC | ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM (Device) | Food and Beverage | Cash or cash equivalent | $11.07 | General |
| Category: Peripheral Intervention | ||||||
| 08/21/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Lithoplasty | ||||||
| 08/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Cardio-renal | ||||||
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,175.00 | General |
| Category: DIABETES | ||||||
| 07/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/18/2024 | AngioDynamics, Inc. | AURYON LASER SYSTEM 100-120 VAC (Device) | Food and Beverage | In-kind items and services | $69.11 | General |
| Category: PAD | ||||||
| 06/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $54.33 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: DIABETES | ||||||
| 05/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,608.00 | General |
| Category: Cardio-renal | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Auryon iDissection Below the Knee Study | AngioDynamics, Inc. | $90,728 | 2 |
| Acute Procedural and Long-Term Outcomes after BTK Intervention with the Auryon Laser: Intravascular Ultrasound Assessment and Correlation with Angiographic findings | AngioDynamics, Inc. | $80,000 | 1 |
| Mimics-3D-USA Registry Study | Veryan Medical Incorporated | $41,600 | 2 |
| Pathfinder Study | AngioDynamics, Inc. | $10,800 | 1 |
| Tack Optimized Balloon Angioplasty Study of the Tack Endovascular in Femoropoliteal Arteries (TOBA II) | Philips Electronics North America Corporation | $7,136 | 2 |
| PATHFINDER | AngioDynamics, Inc. | $2,700 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 3,482 | 4,263 | $1.5M | $407,453 |
| 2022 | 51 | 3,935 | 4,613 | $2.0M | $533,877 |
| 2021 | 56 | 3,806 | 4,617 | $1.9M | $548,873 |
| 2020 | 58 | 3,371 | 4,276 | $1.7M | $463,921 |
Total Patients
14,594
Total Services
17,769
Medicare Billing
$2.0M
Procedure Codes
222
All Medicare Procedures & Services
222 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 160 | 161 | $438,650 | $116,559 | 26.6% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 29 | 45 | $194,940 | $42,772 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 322 | 382 | $104,286 | $30,860 | 29.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 233 | 238 | $137,552 | $29,537 | 21.5% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 155 | 312 | $35,051 | $26,024 | 74.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 277 | 278 | $104,467 | $25,232 | 24.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 93 | 93 | $48,063 | $11,625 | 24.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 38 | 38 | $47,843 | $11,342 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 175 | $32,320 | $9,909 | 30.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 58 | 236 | $15,555 | $9,738 | 62.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 174 | 174 | $30,276 | $8,847 | 29.2% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 51 | 54 | $35,632 | $8,784 | 24.7% |
| 71275 | Ct scan of blood vessels of chest with contrast | Office | 2023 | 107 | 107 | $26,750 | $6,628 | 24.8% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 37 | 74 | $7,819 | $5,705 | 73.0% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 90 | 94 | $26,331 | $5,542 | 21.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $18,765 | $4,917 | 26.2% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 57 | 61 | $16,960 | $4,181 | 24.7% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Office | 2023 | 44 | 44 | $14,256 | $3,701 | 26.0% |
| 75635 | Ct scan of abdominal aorta and both leg arteries with contrast | Office | 2023 | 42 | 43 | $14,018 | $3,410 | 24.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 57 | $10,488 | $3,356 | 32.0% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 27 | 27 | $13,576 | $3,313 | 24.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 312 | 352 | $16,192 | $3,204 | 19.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 32 | $11,136 | $3,090 | 27.7% |
| 74174 | Ct scan of blood vessels of abdomen and pelvis with contrast | Office | 2023 | 37 | 37 | $11,100 | $2,896 | 26.1% |
| 93924 | Ultrasound of leg arteries at rest and after exercise | Office | 2023 | 23 | 23 | $10,718 | $2,259 | 21.1% |
About Dr. Nicolas Shammas, M.D
Dr. Nicolas Shammas, M.D is a Interventional Cardiology healthcare provider based in Davenport, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922087857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicolas Shammas, M.D has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $47,695 received in 2024. These payments were reported across 1,028 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($922,049).
As a Medicare-enrolled provider, Shammas has provided services to 14,594 Medicare beneficiaries, totaling 17,769 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 222 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Davenport, IA
- Active Since 01/10/2006
- Last Updated 02/10/2021
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1922087857
Products in Payments
- XARELTO (Drug) $317,968
- JARDIANCE (Drug) $263,819
- AURYON LASER SYSTEM 100-120 VAC (Device) $176,471
- ENTRESTO (Drug) $106,461
- VERQUVO (Drug) $59,841
- Kerendia (Drug) $51,374
- JETSTREAM (Device) $46,109
- BioMimics (Device) $41,600
- TRULICITY (Drug) $38,060
- Repatha (Biological) $35,342
- NEXLIZET (Drug) $29,287
- FLEX Scoring Catheter (Device) $24,709
- OMNILINK ELITE (Device) $12,878
- Tack Endovascular System (Device) $11,715
- FLAIR (Device) $10,868
- LifeVest (Device) $10,221
- GENERAL - ATHERECTOMY (Device) $7,264
- IGT Devices Und (Device) $7,203
- Auryon Laser System 100-120 Vac (Device) $6,266
- Vascular Lithotripsy (Device) $5,970
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.